Human Conjunctival Fibroblasts (HConF)

Cat.No.: CSC-7801W

Species: Human

Source: Conjunctiva; Eye

Cell Type: Fibroblast

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-7801W
Description
Human Conjunctival Fibroblasts (HConF) from Creative Bioarray are isolated from human conjunctiva. HConF are cryopreserved at primary culture and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HConF are characterized by their spindle morphology and immunofluorescent method with antibody to fibronectin. HConF are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HConF are guaranteed to further expand for 15 population doublings at the condition provided by Creative Bioarray.
Species
Human
Source
Conjunctiva; Eye
Cell Type
Fibroblast
Disease
Normal
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human conjunctival fibroblasts (HConF) are primary fibroblast cells isolated from the healthy conjunctival tissue of adult donors, typically from the bulbar and palpebral conjunctiva that line the ocular surface. Morphologically, HConF cells exhibit the classical spindle‑shaped, fibroblastic morphology in two‑dimensional culture and form an interlaced network upon confluence. They express canonical mesenchymal markers such as vimentin, fibronectin, collagen I and IV, and acquire α‑smooth muscle actin (α‑SMA) upon activation. Importantly, these cells lack epithelial cytokeratins, confirming their non‑epithelial lineage and origin.

Functionally, HConF are highly sensitive to various profibrotic stimuli. Transforming growth factor‑β (TGF‑β1/β2) robustly up‑regulates extracellular‑matrix components (collagen I/IV, fibronectin) and α‑SMA, recapitulating conjunctival fibrosis. HConF also respond to other fibrotic stimuli and signaling pathways including fibroblast growth factor‑2, Wnt/β‑catenin, and PLC‑γ to regulate proliferation, migration, and contractility. Metabolic profiling revealed modest changes in oxidative phosphorylation and glycolysis under fibrotic stimulation, particularly in three‑dimensional spheroid models.

Taken together, these characteristics make HConF an attractive and multipurpose platform for exploring ocular surface fibrosis, allergic conjunctivitis, and drug screening. HConF are used in 2D and 3D cultures, as well as co‑culture systems with epithelial or immune cells and in gene‑silencing studies to map out signaling networks and identify therapeutic targets. As such, HConF are invaluable in both basic ophthalmic research and translational studies aiming to address postoperative scarring and chronic inflammatory diseases of the eye.

The sGC Stimulator BAY 41-2272 Has No Effect on Cell Viability and Inhibits TGFβ1-Induced Proliferation of Human Conjunctival Fibroblasts

Conjunctival fibrosis is an important pathological outcome in a number of ocular diseases that is the result of chronic inflammation leading to aberrant wound healing and scar formation. Fioretto et al. assessed the in vitro impact of sGC stimulation with BAY 41-2272 on TGFβ1-mediated profibrotic activation of human conjunctival fibroblasts.

Figure 1 Stimulation of sGC with BAY 41-2272 robustly increased cGMP levels in human conjunctival fibroblasts. To exclude potential side effects of BAY 41-2272, they used Annexin V/PI flow cytometry to examine cell viability. They did not observe any significant differences in the number of viable, early apoptotic, late apoptotic, and necrotic cells in all conditions (Fig. 2A, B), suggesting that treatment with recombinant human TGFβ1, BAY 41-2272 (1 μM or 10 μM), alone or in combination, did not impact viability. The WST-1 assay demonstrated that TGFβ1 alone enhanced proliferation while BAY 41-2272 alone did not (Fig. 2C). In contrast, pre-treatment of fibroblasts with BAY 41-2272 before the TGFβ1 challenge blocked TGFβ1-induced proliferation, with only 10 μM BAY 41-2272 being sufficient to preserve basal rates of proliferation (Fig. 2C). Based on these data, they only used 10 μM BAY 41-2272 in thier subsequent experiments.

Intracellular levels of cGMP in human conjunctival fibroblasts.

Fig. 1. Intracellular levels of cGMP in human conjunctival fibroblasts (Fioretto B S, Rosa I, et al., 2024).

The sGC stimulator BAY 41-2272 does not affect human conjunctival fibroblast viability and inhibits TGFβ1-induced cell proliferation.

Fig. 2. The sGC stimulator BAY 41-2272 does not affect human conjunctival fibroblast viability and inhibits TGFβ1-induced cell proliferation (Fioretto B S, Rosa I, et al., 2024).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products